Malinczak, C.-A.; Schuler, C.F.; Duran, A.J.; Rasky, A.J.; Mire, M.M.; Núñez, G.; Lukacs, N.W.; Fonseca, W.
NLRP3-Inflammasome Inhibition during Respiratory Virus Infection Abrogates Lung Immunopathology and Long-Term Airway Disease Development. Viruses 2021, 13, 692.
https://doi.org/10.3390/v13040692
AMA Style
Malinczak C-A, Schuler CF, Duran AJ, Rasky AJ, Mire MM, Núñez G, Lukacs NW, Fonseca W.
NLRP3-Inflammasome Inhibition during Respiratory Virus Infection Abrogates Lung Immunopathology and Long-Term Airway Disease Development. Viruses. 2021; 13(4):692.
https://doi.org/10.3390/v13040692
Chicago/Turabian Style
Malinczak, Carrie-Anne, Charles F. Schuler, Angela J. Duran, Andrew J. Rasky, Mohamed M. Mire, Gabriel Núñez, Nicholas W. Lukacs, and Wendy Fonseca.
2021. "NLRP3-Inflammasome Inhibition during Respiratory Virus Infection Abrogates Lung Immunopathology and Long-Term Airway Disease Development" Viruses 13, no. 4: 692.
https://doi.org/10.3390/v13040692
APA Style
Malinczak, C.-A., Schuler, C. F., Duran, A. J., Rasky, A. J., Mire, M. M., Núñez, G., Lukacs, N. W., & Fonseca, W.
(2021). NLRP3-Inflammasome Inhibition during Respiratory Virus Infection Abrogates Lung Immunopathology and Long-Term Airway Disease Development. Viruses, 13(4), 692.
https://doi.org/10.3390/v13040692
